Correlation Between Entrada Therapeutics and China Resources

Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and China Resources at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and China Resources into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entrada Therapeutics and China Resources Power, you can compare the effects of market volatilities on Entrada Therapeutics and China Resources and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of China Resources. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and China Resources.

Diversification Opportunities for Entrada Therapeutics and China Resources

-0.79

Correlation Coefficient

Entrada Therapeutics  China Resources

Pay attention - limited upside

The 3 months correlation between Entrada and China is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and China Resources Power in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Resources Power and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with China Resources. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Resources Power has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and China Resources go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and China Resources

Given the investment horizon of 90 days Entrada Therapeutics is expected to generate 1.63 times more return on investment than China Resources. However, Entrada Therapeutics is 1.63 times more volatile than China Resources Power. It trades about 0.11 of its potential returns per unit of risk. China Resources Power is currently generating about -0.07 per unit of risk. If you would invest  1,457  in Entrada Therapeutics on September 23, 2024 and sell it today you would earn a total of  302.00  from holding Entrada Therapeutics or generate 20.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Entrada Therapeutics  vs.  China Resources Power

Entrada Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

China Resources Power

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China Resources Power has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's forward-looking indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Entrada Therapeutics and China Resources

The main advantage of trading using opposite Entrada Therapeutics and China Resources positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, China Resources can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Resources will offset losses from the drop in China Resources' long position.

The idea behind Entrada Therapeutics and China Resources Power pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.